Skip to main content
Log in

Novel prognostic score for patients with gastric carcinoma

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

The lack of a simple criterion for gastric carcinoma creates a persistent challenge for clinicians trying to provide patients with useful prognostic information. The aim of this study was to identify baseline prognostic factors, and use this information to establish a simple criterion to predict outcome in gastric carcinoma.

Methods

Between 2005 and 2010, 155 patients with gastric carcinoma, were enrolled. Clinicopathologic prognostic factors were evaluated by univariate and multivariate analysis.

Results

Of the 155 patients, 48 (30.9%) died. Three independent poor prognostic factors were identified by multivariate analysis: gross type > or = 3 (hazard ratio [HR], 1.564; 95% CI, 1.067 to 2.294), peritoneal dissemination (HR, 3.750; 95% CI, 1.760 to 7.989) and lymphatic duct invasion (HR, 3.578; 95% CI, 1.422 to 9.004). One point was added for each category among three independent prognostic factors. Prognostic score (PS) was determined by an aggregate of these points for each category. There existed a significant difference between survival of patients with PS 0 or 1 and 2 (P < 0.0001).

Conclusion

Three poor prognostic factors were identified and a simple criteria was devised. Information from this analysis can be used to predict prognosis of gastric carcinoma with a strict stratification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Landry CS, Brock G, Scoggins CR, et al. A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol, 2009, 16: 51–60.

    Article  PubMed  Google Scholar 

  2. Yasuda N, Nakashima O, Ohnaka T, et al. Novel clinical staging for patients with end-stage gastrointestinal carcinoma. Surg Today, 2006, 36: 25–29.

    Article  PubMed  Google Scholar 

  3. Nozoe T, Ninomiya M, Maeda T, et al. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today, 2010, 40: 440–443.

    Article  PubMed  Google Scholar 

  4. Nozoe T, Iguchi T, Egashira A, et al. Pathological prognostic score as a simple criterion to predict outcome in gastric carcinoma. J Surg Oncol, 2010, 102: 73–76.

    Article  PubMed  Google Scholar 

  5. Park DI, Yun JW, Park JH, et al. HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci, 2006, 51: 1371–1379.

    Article  PubMed  CAS  Google Scholar 

  6. Matsubara J, Yamada Y, Hirashima Y, et al. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer. Clin Cancer Res, 2008, 14: 3022–3029.

    Article  PubMed  CAS  Google Scholar 

  7. Jung JJ, Noh S, Jeung HC, et al. Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression. Cancer Sci, 2010, 101: 2200–2206.

    Article  PubMed  CAS  Google Scholar 

  8. Zhang BH, Wang XH, Yue HY, et al. Clinical analysis of long-term survivors for unresectable hepatocellular carcinoma. Chinese-German J Clin Oncol, 2010, 9: 161–164.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Baihong Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, B., Yue, H., Chen, L. et al. Novel prognostic score for patients with gastric carcinoma. Chin. -Ger. J. Clin. Oncol. 10, 699–704 (2011). https://doi.org/10.1007/s10330-011-0877-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-011-0877-5

Key words

Navigation